Share Twitter LinkedIn Facebook Email Mark Levis, MD, PhD, explains the the impact of next-generation sequencing in AML at Annual Meeting 2018.
Molecular Changes and Patient Stratification – Parrish Phimes, MD Acute Myelogenous Leukemia 2 Mins Read
Inequities in AML Outcomes: Comprehensive Discussion by Pramilla Krishnamurthy Acute Myelogenous Leukemia 2 Mins Read